Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 11, Issue 8, Pages 633-652
Publisher
Springer Nature
Online
2012-08-01
DOI
10.1038/nrd3800
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A retrospective review of autoinflammatory diseases in Saudi children at a rheumatology clinic
- (2017) Abdullatif Alenazi et al. ANNALS OF SAUDI MEDICINE
- Rapid and Sustained Remission of Systemic Juvenile Idiopathic Arthritis-Associated Macrophage Activation Syndrome Through Treatment With Anakinra and Corticosteroids
- (2012) Normi Bruck et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Efficacy and Safety of CE-224,535, an Antagonist of P2X7 Receptor, in Treatment of Patients with Rheumatoid Arthritis Inadequately Controlled by Methotrexate
- (2012) T. C. STOCK et al. JOURNAL OF RHEUMATOLOGY
- Abstract A211: A phase I study of MABp1, a first-in-human, first-true human monoclonal antibody against the IL-1 in patients with advanced cancers.
- (2012) D. S. Hong et al. MOLECULAR CANCER THERAPEUTICS
- Interleukin-1 Inhibition and Fatigue in Primary Sjögren's Syndrome – A Double Blind, Randomised Clinical Trial
- (2012) Katrine Brække Norheim et al. PLoS One
- Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure
- (2012) Benjamin W. Van Tassell et al. PLoS One
- Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
- (2011) Paul M Ridker et al. AMERICAN HEART JOURNAL
- Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study
- (2011) Ahmet Gül et al. ANNALS OF THE RHEUMATIC DISEASES
- The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis
- (2011) I. Mitroulis et al. ANNALS OF THE RHEUMATIC DISEASES
- Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study
- (2011) N. Schlesinger et al. ANNALS OF THE RHEUMATIC DISEASES
- Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes
- (2011) J. B. Kuemmerle-Deschner et al. ANNALS OF THE RHEUMATIC DISEASES
- On-demand anakinra treatment is effective in mevalonate kinase deficiency
- (2011) E. J. Bodar et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis
- (2011) Jelena Vojinovic et al. ARTHRITIS AND RHEUMATISM
- A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
- (2011) Nicolino Ruperto et al. ARTHRITIS AND RHEUMATISM
- Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
- (2011) C. A. Dinarello BLOOD
- Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study
- (2011) Rieke Alten et al. BMC MUSCULOSKELETAL DISORDERS
- IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures
- (2011) Annamaria Vezzani et al. BRAIN BEHAVIOR AND IMMUNITY
- Hyper-IgD syndrome or mevalonate kinase deficiency
- (2011) Monique Stoffels et al. CURRENT OPINION IN RHEUMATOLOGY
- Muckle-Wells Syndrome Effectively Treated with Canakinumab: Is the Recommended Dosing Schedule Mandatory?
- (2011) Simon M. Mueller et al. DERMATOLOGY
- Inhibition of IL-1 Improves Fatigue in Type 2 Diabetes
- (2011) C. Cavelti-Weder et al. DIABETES CARE
- Therapeutic potential of new antiinflammatory drugs
- (2011) Annamaria Vezzani et al. EPILEPSIA
- Association of interleukin-1 gene polymorphisms with sudden sensorineural hearing loss and Ménière’s disease
- (2011) T. Furuta et al. International Journal of Immunogenetics
- Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome
- (2011) Heleen D. de Koning et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment with Anakinra Improves Disposition Index But Not Insulin Sensitivity in Nondiabetic Subjects with the Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
- (2011) Edwin J. P. van Asseldonk et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS)
- (2011) Ariel C. Bulua et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-1 Is Overexpressed and Aberrantly Regulated in Corticosteroid Nonresponders with Autoimmune Inner Ear Disease
- (2011) S. Pathak et al. JOURNAL OF IMMUNOLOGY
- IL-1 and IL-1 Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation
- (2011) P. Rider et al. JOURNAL OF IMMUNOLOGY
- Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)?a new autoinflammatory syndrome distinct from PAPA syndrome
- (2011) Markus Braun-Falco et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- IL-1 Receptor Antagonist Reduces Inflammation in Hemodialysis Patients
- (2011) A. M. Hung et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
- (2011) Bolormaa Vandanmagsar et al. NATURE MEDICINE
- Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure
- (2011) K. Stankovic Stojanovic et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cryopyrin-Associated Periodic Syndromes
- (2011) Neda Ahmadi et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Preliminary studies related to anti-interleukin-1β therapy in children with newly diagnosed type 1 diabetes
- (2011) Kathryn M. Sumpter et al. PEDIATRIC DIABETES
- Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade
- (2011) S. Stojanov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1
- (2011) Y. Berda-Haddad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin-1 Targeting Drugs in Familial Mediterranean Fever: A Case Series and a Review of the Literature
- (2011) Ulrich Meinzer et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Cancer-related inflammation: Common themes and therapeutic opportunities
- (2011) Frances R. Balkwill et al. SEMINARS IN CANCER BIOLOGY
- NLRP3 E311K mutation in a large family with Muckle-Wells syndrome - description of a heterogeneous phenotype and response to treatment
- (2011) Jasmin B Kuemmerle-Deschner et al. ARTHRITIS RESEARCH & THERAPY
- Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)
- (2011) Jasmin B Kuemmerle-Deschner et al. ARTHRITIS RESEARCH & THERAPY
- Desperately looking for the right target in osteoarthritis: the anti-IL-1 strategy
- (2011) Xavier Chevalier et al. ARTHRITIS RESEARCH & THERAPY
- A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee
- (2011) Stanley B Cohen et al. ARTHRITIS RESEARCH & THERAPY
- Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study
- (2011) Isabelle Koné-Paut et al. ARTHRITIS RESEARCH & THERAPY
- Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study
- (2011) Naomi Schlesinger et al. ARTHRITIS RESEARCH & THERAPY
- Current Status of Understanding the Pathogenesis and Management of Patients With NOMID/CINCA
- (2011) Raphaela Goldbach-Mansky Current Rheumatology Reports
- Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review on therapy with biological drugs and case report
- (2010) M Korppi et al. ACTA PAEDIATRICA
- Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study)
- (2010) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease
- (2010) L Naumann et al. ANNALS OF THE RHEUMATIC DISEASES
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- Hidradenitis Suppurativa and Concomitant Pyoderma Gangrenosum
- (2010) Jennifer L. Hsiao et al. ARCHIVES OF DERMATOLOGY
- Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study
- (2010) Alexander So et al. ARTHRITIS AND RHEUMATISM
- Engagement of fatty acids with toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis
- (2010) Leo A. B. Joosten et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome
- (2010) Jasmin B. Kuemmerle-Deschner et al. ARTHRITIS AND RHEUMATISM
- Why not treat human cancer with interleukin-1 blockade?
- (2010) Charles A. Dinarello CANCER AND METASTASIS REVIEWS
- Anti-inflammatory Agents: Present and Future
- (2010) Charles A. Dinarello CELL
- Autoinflammatory Disease Reloaded: A Clinical Perspective
- (2010) Daniel L. Kastner et al. CELL
- The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin Sensitivity
- (2010) Rinke Stienstra et al. Cell Metabolism
- Cytophagic histiocytic panniculitis and hemophagocytic lymphohistiocytosis: an overview
- (2010) Iris K. Aronson et al. Dermatologic Therapy
- Downregulation of Adipose Tissue Fatty Acid Trafficking in Obesity: A Driver for Ectopic Fat Deposition?
- (2010) S. E. McQuaid et al. DIABETES
- Interleukin-1β modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse
- (2010) Antonio Abbate et al. EUROPEAN JOURNAL OF HEART FAILURE
- The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
- (2010) I. Solovic et al. EUROPEAN RESPIRATORY JOURNAL
- The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis
- (2010) Joost Frans Swart et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Anakinra efficacy in a Caucasian patient with renal AA amyloidosis secondary to cryopyrin-associated periodic syndrome
- (2010) Tassadit Aït-Abdesselam et al. JOINT BONE SPINE
- Intravenous Anakinra can Achieve Experimentally Effective Concentrations in the Central Nervous System within a Therapeutic Time Window: Results of a Dose-Ranging Study
- (2010) James Galea et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Follow-Up and Quality of Life of Patients with Cryopyrin-Associated Periodic Syndromes Treated with Anakinra
- (2010) Loredana Lepore et al. JOURNAL OF PEDIATRICS
- Macrophage Activation Syndrome Treated with Anakinra
- (2010) M. DURAND et al. JOURNAL OF RHEUMATOLOGY
- Anti-Interleukin 1 Treatment for Patients with Familial Mediterranean Fever Resistant to Colchicine: Table 1.
- (2010) SEZA ÖZEN et al. JOURNAL OF RHEUMATOLOGY
- Rückbildung der Schwerhörigkeit bei einer Patientin mit Muckle-Wells-Syndrom unter Therapie mit Anakinra
- (2010) A. Klein et al. KLINISCHE PADIATRIE
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes
- (2010) Seth L Masters et al. NATURE IMMUNOLOGY
- Blockade of interleukin 1 in type 1 diabetes mellitus
- (2010) Thomas Mandrup-Poulsen et al. Nature Reviews Endocrinology
- Update on gout: new therapeutic strategies and options
- (2010) Robert Terkeltaub Nature Reviews Rheumatology
- Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
- (2010) Mohit Kapoor et al. Nature Reviews Rheumatology
- Neurologic manifestations of the cryopyrin-associated periodic syndrome
- (2010) J. L. Kitley et al. NEUROLOGY
- Effect of anakinra on arthropathy in CINCA/NOMID syndrome
- (2010) Takako Miyamae et al. Pediatric Rheumatology
- Blocking IL-1 to slow down progression of ALS?
- (2010) J. W. M. van der Meer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome
- (2010) A. Simon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutant superoxide dismutase 1-induced IL-1 accelerates ALS pathogenesis
- (2010) F. Meissner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential release of chromatin-bound IL-1 discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation
- (2010) I. Cohen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra
- (2010) M. Colina et al. RHEUMATOLOGY
- First observation of the efficacy of IL-1ra to treat tophaceous gout of the lumbar spine
- (2010) T. Funck-Brentano et al. RHEUMATOLOGY
- Pneumonia in a patient with familial Mediterranean fever successfully treated with anakinra—case report and review
- (2010) Stefanie Hennig et al. RHEUMATOLOGY INTERNATIONAL
- Erosive osteoarthritis of the hand: clinical experience with anakinra
- (2009) L Bacconnier et al. ANNALS OF THE RHEUMATIC DISEASES
- Demyelinating events in rheumatoid arthritis after drug exposures
- (2009) S. Bernatsky et al. ANNALS OF THE RHEUMATIC DISEASES
- The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study
- (2009) R Terkeltaub et al. ANNALS OF THE RHEUMATIC DISEASES
- Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
- (2009) Seth L. Masters et al. Annual Review of Immunology
- The Inflammasomes: Guardians of the Body
- (2009) Fabio Martinon et al. Annual Review of Immunology
- Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1β receptor antagonist (anakinra): An unrecognized autoinflammatory disease?
- (2009) Paolo Picco et al. ARTHRITIS AND RHEUMATISM
- Functional analysis of the osteoarthritis susceptibility-associatedGDF5regulatory polymorphism
- (2009) Rainer J. Egli et al. ARTHRITIS AND RHEUMATISM
- Case of anakinra as a steroid-sparing agent for gout inflammation
- (2009) Sarah B. Gratton et al. ARTHRITIS AND RHEUMATISM
- Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double-blind, placebo-controlled study
- (2009) X. Chevalier et al. ARTHRITIS AND RHEUMATISM
- Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome
- (2009) Belinda Nedjai et al. ARTHRITIS AND RHEUMATISM
- Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome
- (2009) Bénédicte Neven et al. ARTHRITIS AND RHEUMATISM
- Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy
- (2009) Jae J. Chae et al. BRITISH JOURNAL OF HAEMATOLOGY
- Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet’s disease
- (2009) Yelda Bilginer et al. CLINICAL RHEUMATOLOGY
- IL-1 Inhibition With Anakinra in a Patient With Refractory Gout
- (2009) Dushyant Singh et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure
- (2009) Nadia Announ et al. JOINT BONE SPINE
- In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes
- (2009) Helen J. Lachmann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Role of Macrophage-Derived IL-1 in Induction and Maintenance of Angiogenesis
- (2009) Y. Carmi et al. JOURNAL OF IMMUNOLOGY
- Rationale for IL-1β Targeted Therapy for Ischemia-Reperfusion Induced Pulmonary and Other Complications in Sickle Cell Disease
- (2009) Alan A. Wanderer JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Anakinra for Rheumatoid Arthritis: A Systematic Review
- (2009) M. MERTENS et al. JOURNAL OF RHEUMATOLOGY
- Inflammation in Atherosclerosis
- (2009) Peter Libby et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Graft-versus-host disease
- (2009) James LM Ferrara et al. LANCET
- Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component
- (2009) John A. Lust et al. MAYO CLINIC PROCEEDINGS
- The role of microparticles in the pathogenesis of rheumatic diseases
- (2009) Christian Beyer et al. Nature Reviews Rheumatology
- An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
- (2009) Ivona Aksentijevich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
- (2009) Helen J. Lachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Autoinflammatory Disease Due to Homozygous Deletion of theIL1RNLocus
- (2009) Sreelatha Reddy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intravitreal Anakinra Inhibits Choroidal Neovascular Membrane Growth in a Rat Model
- (2009) Jeffrey L. Olson et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Alternate Splicing of Interleukin-1 Receptor Type II (IL1R2) In Vitro Correlates with Clinical Glucocorticoid Responsiveness in Patients with AIED
- (2009) Andrea Vambutas et al. PLoS One
- Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome
- (2009) Hiba M. Shendi et al. RHEUMATOLOGY INTERNATIONAL
- Successful treatment of resistant pseudogout with anakinra
- (2008) Dennis McGonagle et al. ARTHRITIS AND RHEUMATISM
- The pattern of response to anti–interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis
- (2008) Marco Gattorno et al. ARTHRITIS AND RHEUMATISM
- Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms
- (2008) Kejian Zhang et al. ARTHRITIS AND RHEUMATISM
- Persistent efficacy of anakinra in patients with tumor necrosis factor receptor–associated periodic syndrome
- (2008) M. Gattorno et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies
- (2008) Hal M. Hoffman et al. ARTHRITIS AND RHEUMATISM
- Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis
- (2008) Ignatios Ikonomidis et al. CIRCULATION
- Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, Inhibits Apoptosis in Experimental Acute Myocardial Infarction
- (2008) Antonio Abbate et al. CIRCULATION
- Blunted neurogenesis and gliosis due to transgenic overexpression of human soluble IL-1ra in the mouse
- (2008) Stefan Spulber et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- IL-1 blockade in Schnitzler syndrome: Ex vivo findings correlate with clinical remission
- (2008) John G. Ryan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Long-Term Follow-Up, Clinical Features, and Quality of Life in a Series of 103 Patients With Hyperimmunoglobulinemia D Syndrome
- (2008) Jeroen C. H. van der Hilst et al. MEDICINE
- Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation
- (2008) C. Moser et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Administration of interleukin-1 receptor antagonist ameliorates renal ischemia-reperfusion injury
- (2008) Krisztina Rusai et al. TRANSPLANT INTERNATIONAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started